Andreas R. Baudy

705 total citations
12 papers, 528 citations indexed

About

Andreas R. Baudy is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andreas R. Baudy has authored 12 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Andreas R. Baudy's work include Muscle Physiology and Disorders (3 papers), Medical Imaging Techniques and Applications (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Andreas R. Baudy is often cited by papers focused on Muscle Physiology and Disorders (3 papers), Medical Imaging Techniques and Applications (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Andreas R. Baudy collaborates with scholars based in United States, Switzerland and Belgium. Andreas R. Baudy's co-authors include Eric P. Hoffman, Raju V. Pusapati, Jeff Settleman, Wendy Sandoval, Marie Evangelista, Anneleen Daemen, Benjamin Haley, Georgia Hatzivassiliou, Min Gao and Catherine Wilson and has published in prestigious journals such as Cancer Cell, Cancer Research and Scientific Reports.

In The Last Decade

Andreas R. Baudy

12 papers receiving 515 citations

Peers

Andreas R. Baudy
Chloe J. Peach United States
Oscar Sudilovsky United States
Bin Lan China
Jin Gong China
Andreas R. Baudy
Citations per year, relative to Andreas R. Baudy Andreas R. Baudy (= 1×) peers Yuichiro Higuchi

Countries citing papers authored by Andreas R. Baudy

Since Specialization
Citations

This map shows the geographic impact of Andreas R. Baudy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas R. Baudy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas R. Baudy more than expected).

Fields of papers citing papers by Andreas R. Baudy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas R. Baudy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas R. Baudy. The network helps show where Andreas R. Baudy may publish in the future.

Co-authorship network of co-authors of Andreas R. Baudy

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas R. Baudy. A scholar is included among the top collaborators of Andreas R. Baudy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas R. Baudy. Andreas R. Baudy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Ha, Sha, Joseph P. Davide, Joseph P. Califano, et al.. (2021). Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO. Scientific Reports. 11(1). 7432–7432. 11 indexed citations
2.
Hafey, Michael J., Robert Houle, Keith Q. Tanis, et al.. (2020). A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery. Drug Metabolism and Disposition. 48(11). 1147–1160. 14 indexed citations
3.
Baudy, Andreas R., Monicah A. Otieno, Philip Hewitt, et al.. (2019). Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab on a Chip. 20(2). 215–225. 99 indexed citations
4.
Pusapati, Raju V., Anneleen Daemen, Catherine Wilson, et al.. (2016). mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells. Cancer Cell. 29(4). 548–562. 172 indexed citations
5.
Baudy, Andreas R., Erica Reeves, Jesse M. Damsker, et al.. (2012). Δ-9,11 Modification of Glucocorticoids Dissociates Nuclear Factor-κB Inhibitory Efficacy from Glucocorticoid Response Element-Associated Side Effects. Journal of Pharmacology and Experimental Therapeutics. 343(1). 225–232. 26 indexed citations
6.
Baudy, Andreas R., Taner Dogan, Klaus P. Hoeflich, et al.. (2012). FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973. EJNMMI Research. 2(1). 22–22. 52 indexed citations
7.
Baudy, Andreas R., Taner Dogan, Judith E. Flores, et al.. (2012). Abstract 911: Vemurafenib FDG-PET preclinical imaging outcomes across BRAF V600E mutant and resistant tumors. Cancer Research. 72(8_Supplement). 911–911. 1 indexed citations
8.
Williams, Simon‐Peter, et al.. (2012). The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constant. EJNMMI Research. 2(1). 35–35. 6 indexed citations
9.
Hoffman, Eric P., Arthur A. Levin, Shin’ichi Takeda, et al.. (2011). Restoring Dystrophin Expression in Duchenne Muscular Dystrophy Muscle. American Journal Of Pathology. 179(1). 12–22. 77 indexed citations
10.
Baudy, Andreas R., Arpana Sali, Sarah Jordan, et al.. (2010). Non-invasive Optical Imaging of Muscle Pathology in mdx Mice Using Cathepsin Caged Near-Infrared Imaging. Molecular Imaging and Biology. 13(3). 462–470. 25 indexed citations
11.
Baudy, Andreas R., et al.. (2009). A robust in vitro screening assay to identify NF-κB inhibitors for inflammatory muscle diseases. International Immunopharmacology. 9(10). 1209–1214. 28 indexed citations
12.
McIlvain, H. Beal, Andreas R. Baudy, Kelly Sullivan, et al.. (2006). Pituitary adenylate cyclase-activating peptide (PACAP) induces differentiation in the neuronal F11 cell line through a PKA-dependent pathway. Brain Research. 1077(1). 16–23. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026